Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Total 13F shares
-
28,422,158
-
Share change
-
+281,698
-
Total reported value
-
$7,006,772,337
-
Put/Call ratio
-
41%
-
Price per share
-
$246.54
-
Number of holders
-
331
-
Value change
-
+$81,325,375
-
Number of buys
-
171
-
Number of sells
-
133
Institutional Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q4 2025
As of 31 Dec 2025,
Krystal Biotech, Inc. - COMMON STOCK (KRYS) was held by
331 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,422,158 shares.
The largest 10 holders included
FMR LLC, BlackRock, Inc., Avoro Capital Advisors LLC, VANGUARD GROUP INC, STATE STREET CORP, Soleus Capital Management, L.P., Capital World Investors, Redmile Group, LLC, Hood River Capital Management LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
331
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.